Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study

SIMPLE SUMMARY: This prospective translational study evaluated whether the presence of circulating tumor cells (CTCs) in the peripheral blood (PB) correlates with efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC). This study demonstrated that 84% of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koinis, Filippos, Zafeiriou, Zafeiris, Messaritakis, Ippokratis, Katsaounis, Panagiotis, Koumarianou, Anna, Kontopodis, Emmanouil, Chantzara, Evangelia, Aidarinis, Chrissovalantis, Lazarou, Alexandros, Christodoulopoulos, George, Emmanouilides, Christos, Hatzidaki, Dora, Kallergi, Galatea, Georgoulias, Vassilis, Kotsakis, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527446/
https://www.ncbi.nlm.nih.gov/pubmed/37760481
http://dx.doi.org/10.3390/cancers15184511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527446/
https://www.ncbi.nlm.nih.gov/pubmed/37760481
http://dx.doi.org/10.3390/cancers15184511

Ejemplares similares